Make the Diagnosis: This Rash? Don ’t Blame the Dog
(MedPage Today) -- (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 20, 2022 Category: Dermatology Source Type: news
Long-Term Data Reinforce Targeted Combo Versus Single Agent for Advanced Melanoma
(MedPage Today) -- Combination targeted therapy significantly improved 5-year progression-free survival (PFS) and overall survival (OS) versus single-agent vemurafenib (Zelboraf) and was numerically superior to single-agent encorafenib (Braftovi... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 19, 2022 Category: Dermatology Source Type: news
Topical Gene Therapy Heals Blistering Skin Disease Lesions
(MedPage Today) -- A novel topical gene therapy healed most lesions among patients with dystrophic epidermolysis bullosa, a rare genetic blistering skin disease, the GEM-3 trial showed.
Topical administration of beremagene geperpavec (B-VEC) led... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 14, 2022 Category: Dermatology Source Type: news
mRNA Cancer Vaccine Shows Promise in Early Trial
(MedPage Today) -- An investigational mRNA cancer vaccine met its primary endpoint in a phase IIb study, Moderna and Merck announced Tuesday.
In the KEYNOTE-942 trial, mRNA-4157/V940, in combination with pembrolizumab (Keytruda), reduced the risk... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 14, 2022 Category: Dermatology Source Type: news
mRNA Cancer Vaccine Shows Promise; Sounding the Strep A Alarm; Phasing Out Tobacco
(MedPage Today) -- Note that some links may require subscriptions.
Moderna said its investigational personalized mRNA cancer vaccine, combined with pembrolizumab (Keytruda), cut the risk of melanoma recurrence or death compared with pembrolizumab... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 13, 2022 Category: Dermatology Source Type: news
Drug, Alcohol Deaths in Those Over 65; Medicare Advantage and Heart Attacks
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 10, 2022 Category: Dermatology Source Type: news
Xeljanz Cancer Risks Detailed
(MedPage Today) -- The degree to which the oral rheumatology drug tofacitinib (Xeljanz) seems to promote new malignancies is now fleshed out in the latest, and at least somewhat reassuring, report from a landmark safety study.
Tofacitinib at either... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 7, 2022 Category: Dermatology Source Type: news
What's Behind Boy's Bullous Skin Lesions After Flu Symptoms?
(MedPage Today) -- Mycoplasma pneumonia identified as the culprit in this case of RIME (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 28, 2022 Category: Dermatology Source Type: news
Large U.S. Study Finds No Link Between COVID Vaccine and Shingles
(MedPage Today) -- No association was detected between COVID-19 vaccination and herpes zoster infection in a database study involving more than 2 million individuals in the U.S.
Using a self-controlled risk interval (SCRI) analysis, the risk of... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 16, 2022 Category: Dermatology Source Type: news
Melanoma Resistant to Anti-PD-1 Responds to Tumor Infiltrating Lymphocytes
(MedPage Today) -- Almost a third of post-immunotherapy melanomas responded to cellular therapy with tumor-infiltrating lymphocytes (TILs), data from a multicohort study showed.
Overall, 31.4% of 153 patients responded to lifileucel TILs (LN-144... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 16, 2022 Category: Dermatology Source Type: news
Mixed Results With Fecal Transplant to Stimulate Cancer Immunotherapy Response
(MedPage Today) -- Fecal microbiome transplant (FMT) produced mixed results for stimulating response to immunotherapy in advanced melanoma, according to two preliminary studies.
In one trial, a donor FMT plus a PD-1 inhibitor led to objective... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 15, 2022 Category: Dermatology Source Type: news
Terry Bradshaw's Merkel Cell Carcinoma
(MedPage Today) -- With football back in action this fall, watchers of "Fox NFL Sunday" noticed that commentator and Hall of Fame quarterback Terry Bradshaw looked different. He appeared to have gained weight and seemed unsteady on his feet. Fans... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 11, 2022 Category: Dermatology Source Type: news
Maralixibat Takes Out the Itch of Rare Liver Disease
(MedPage Today) -- WASHINGTON -- Another ileal bile acid transporter inhibitor has demonstrated in a phase III trial the ability to reduce pruritus and serum bile acids for kids with progressive familial intrahepatic cholestasis (PFIC).
In children... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 9, 2022 Category: Dermatology Source Type: news
Make the Diagnosis: What Triggered These Lesions?
(MedPage Today) -- (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 2, 2022 Category: Dermatology Source Type: news
Pebbled Skin and Excessive Hair Growth on a 5-Year-Old's Back
(MedPage Today) -- Just two of the multiple symptoms that began to emerge shortly after birth (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - October 24, 2022 Category: Dermatology Source Type: news
